Stock Earnings

Question 1

What are Palvella Therapeutics Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Palvella Therapeutics Inc has a total asset of $88, Net loss of $-17

Question 2

What are the key financial ratios for PVLA?

Accepted Answer

Palvella Therapeutics Inc's Current ratio is 3.52, has a Net margin is 0, sales per share of $0.

Question 3

How is Palvella Therapeutics Inc's revenue broken down by segment or geography?

Accepted Answer

Palvella Therapeutics Inc largest revenue segment is Biotechnological Applications, at a revenue of 42,810,000 in the most earnings release.For geography, United States, Germany and Australia is the primary market for Palvella Therapeutics Inc, at a revenue of 42,810,000.

Question 4

Is Palvella Therapeutics Inc profitable?

Accepted Answer

no, according to the latest financial statements, Palvella Therapeutics Inc has a net loss of $-17

Question 5

Does Palvella Therapeutics Inc have any liabilities?

Accepted Answer

yes, Palvella Therapeutics Inc has liability of 25

Question 6

How many outstanding shares for Palvella Therapeutics Inc?

Accepted Answer

Palvella Therapeutics Inc has a total outstanding shares of 11.01

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	0	0	42	25	31	29
Revenue Growth (YoY)	-100%	-100%	68%	-19%	7%	-37%
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	6	5	16	16	16	16
Research & Development	22	--	41	52	66	46
Operating Expenses	28	14	58	69	83	63
Other Non Operating Income (Expenses)	3	-3	3	1	2	-3
Pretax Income	-35	-17	-24	-33	-45	-37
Income Tax Expense	0	0	--	--	0	0
Net Income	-35	-17	-24	-33	-45	-37
Net Income Growth	119%	-28.99%	-27%	-27%	22%	32%
Shares Outstanding (Diluted)	11.06	2.23	1.12	0.92	0.8	0.68
Shares Change (YoY)	738%	98%	21%	15%	19%	8%
EPS (Diluted)	-3.16	-7.62	-21.8	-35.89	-56.69	-54.67
EPS Growth	-75%	-65%	-39%	-37%	4%	22%
Free Cash Flow	-22	-10	-53	-60	-8	-48
Free Cash Flow Per Share	-1.98	-4.48	-47.06	-64.72	-9.91	-70.48
Gross Margin	--	--	--	--	--	--
Operating Margin	0%	0%	-35.71%	-172%	-164.51%	-113.79%
Profit Margin	0%	0%	-57.14%	-132%	-145.16%	-127.58%
Free Cash Flow Margin	0%	0%	-126.19%	-240%	-25.8%	-165.51%
EBITDA	--	--	-14	-41	-49	-31
EBITDA Margin	--	--	-33.33%	-164%	-158.06%	-106.89%
D&A For EBITDA	--	--	1	2	2	2
EBIT	-28	-14	-15	-43	-51	-33
EBIT Margin	0%	0%	-35.71%	-172%	-164.51%	-113.79%
Effective Tax Rate	0%	0%	--	--	0%	0%

Palvella Therapeutics Inc (PVLA) Price

PVLA Stock Price Chart

PVLA Income

Follow-Up Questions